Atjaunināt sīkdatņu piekrišanu

E-grāmata: Enzyme Technologies - Metagenomics, Evolution, Biocatalysis and Biosynthesis: Metagenomics, Evolution, Biocatalysis and Biosynthesis [Wiley Online]

Edited by , Edited by , Edited by
Citas grāmatas par šo tēmu:
  • Wiley Online
  • Cena: 155,83 €*
  • * this price gives unlimited concurrent access for unlimited time
Citas grāmatas par šo tēmu:
An authoritative review of the latest developments in the chemical biology of enzymes In the first decade of the twenty-first century, enzymes and their multiple applications have played a critical role in the discovery and development of many new therapeutic agents.This book is a coordinated compilation of research expertise and current opinion uniquely focused on enzymes and their properties and applications.

Compiled by editors with a combined pharmaceutical experience of over sixty years, the text provides in-depth reviews of recent developments in selective topics on biosynthesis, biocatalysis, and chemical biology of enzymes as it applies to drug discovery, development, and manufacture.

The first in a multi-part series on enzymes, this volume features three sections:





New Approaches to Find and Modify Enzymes describes the emerging field of metagenomics, presents the practical applications of directed evolution to enzymes and pathways, and explores approaches for the discovery and design of biocatalysts



Biocatalytic Applications reviews specific applications of different reactions in producing active pharmaceutical ingredients and surveys recent developments employing enzymes in organic synthesis



Biosynthetic Applications goes over successful drug discoveries and developments by combinatorial biosynthesis and reviews the application of combinatorial biosynthesis among multiple compatible hosts





These timely discussions, which cover everything from chemical biology of enzymes, to the redesign of binding and catalytic specificities of enzymes, make this volume a valuable tool for keeping up to date. As such, it is an important read for researchers, students, and professors in the study of biotechnology, life sciences, biochemistry, enzymology, medicinal chemistry, and natural products.
Contributors vii
Preface ix
PART A NEW APPROACHES TO FINDING AND MODIFYING ENZYMES
1(124)
1 Functional Metagenomics as a Technique for the Discovery of Novel Enzymes and Natural Products
3(38)
Luke A. Moe
Matthew D. McMahon
Michael G. Thomas
2 Directed Enzyme and Pathway Evolution
41(36)
Jacob Vick
Claudia Schmidt-Dannert
3 Combining Natural Biodiversity and Molecular-Directed Evolution to Develop New Industrial Biocatalysts and Drugs
77(22)
Laurent Fourage
Celine Ayrinhac
Johann Brot
Christophe Ullmann
Denis Wahler
Jean-Marie Sonet
4 Principles of Enzyme Optimization for the Rapid Creation of Industrial Biocatalysts
99(26)
Richard J. Fox
Lori Giver
PART B BIOCATALYTIC APPLICATIONS
125(126)
5 Enzyme Catalysis in the Synthesis of Active Pharmaceutical Ingredients
127(58)
Animesh Goswami
6 Enzymatic Processes for the Production of Pharmaceutical Intermediates
185(14)
David Rozzell
Jim Lalonde
7 Novel Developments Employing Redox Enzymes: Old Enzymes in New Clothes
199(52)
Kurt Faber
Silvia M. Glueck
Birgit Seisser
Wolfgang Kroutil
PART C BIOSYNTHETIC APPLICATIONS
251(112)
8 Drug Discovery and Development by Combinatorial Biosynthesis
253(32)
Matthew A. DeSieno
Carl A. Denard
Huimin Zhao
9 Reprogramming Daptomycin and A54145 Biosynthesis to Produce Novel Lipopetide Antibiotics
285(24)
Richard H. Baltz
Kien T. Nguyen
Dylan C. Alexander
10 Pathway and Enzyme Engineering and Applications for Glycodiversification
309(54)
Lishan Zhao
Hung-Wen Liu
Index 363
Wu-Kuang Yeh, PhD, is Executive Consultant and was director of research and principal investigator at PreClinOmics, Inc., from 20042010. He was a principal research scientist at Eli Lilly and Company from 19822004. He is the author or coauthor of over 115 abstracts and publications, coeditor of one book, and the holder of six U.S. patents. Hsiu-Chiung Yang, PhD, is a Research Advisor at Eli Lilly and Company. She was a principal research scientist at Eli Lilly and Company from 19982007 and is the author or coauthor of over forty abstracts and publications, as well as co-inventor of one patent.

James R. Mccarthy, PhD, is the author, coauthor, or coeditor of over 125 scientific publications and holder of over forty U.S. patents. He is on the editorial advisory board of the Journal of Medicinal Chemistry and is a past chair of the division of Medicinal Chemistry of the American Chemical Society. He also serves as a Senior Scientific Advisor for the Huntington Disease Research Foundation.